Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents

por Park, Jung-Eun, Hymel, David, Burke, Jr., Terrence R., Lee, Kyung S.
Publicado 2017

Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates

por Nanna, Alex R., Li, Xiuling, Walseng, Even, Pedzisa, Lee, Goydel, Rebecca S., Hymel, David, Burke Jr., Terrence R., Roush, William R., Rader, Christoph
Publicado 2017

Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets

por Lu, Xiuxiu, Nowicka, Urszula, Sridharan, Vinidhra, Liu, Fen, Randles, Leah, Hymel, David, Dyba, Marzena, Tarasov, Sergey G., Tarasova, Nadya I., Zhao, Xue Zhi, Hamazaki, Jun, Murata, Shigeo, Burke, Jr., Terrence R., Walters, Kylie J.
Publicado 2017